ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 130 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -66.7% | 12 | -69.2% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 39 | +44.4% | 0.00% | – |
| Q1 2019 | $3,000 | -40.0% | 27 | -63.5% | 0.00% | – |
| Q4 2018 | $5,000 | -72.2% | 74 | -91.3% | 0.00% | – |
| Q2 2016 | $18,000 | -30.8% | 849 | -4.8% | 0.00% | – |
| Q1 2016 | $26,000 | +8.3% | 892 | +22.2% | 0.00% | – |
| Q4 2015 | $24,000 | -27.3% | 730 | -21.5% | 0.00% | -100.0% |
| Q3 2015 | $33,000 | -19.5% | 930 | +1.9% | 0.00% | 0.0% |
| Q2 2015 | $41,000 | +46.4% | 913 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $28,000 | -94.5% | 913 | -91.0% | 0.00% | -90.9% |
| Q4 2014 | $513,000 | +5030.0% | 10,098 | +3710.6% | 0.01% | – |
| Q3 2014 | $10,000 | – | 265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |